Naples Prognostic Score is an Independent Prognostic Factor in Patients with Small Cell Lung Cancer and Nomogram Predictive Model Established

References

• Li S, Wang H, Yang Z, et al. Naples Prognostic Score as a novel prognostic prediction tool in video-assisted thoracoscopic surgery for early-stage lung cancer: a propensity score matching study. Surg Endosc. 2021;35(7):3679–3697. doi:10.1007/s00464-020-07851-7
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Wang D, Guo D, Shi F, et al. The predictive effect of the systemic immune-inflammation index for patients with small-cell lung cancer. Future Oncol. 2019;15(29):3367–3379. doi:10.2217/fon-2019-0288
   PubMed Web of Science ®Google Scholar
• Frese KK, Simpson KL, Dive C. Small cell lung cancer enters the era of precision medicine. Cancer Cell. 2021;39(3):297–299. doi:10.1016/j.ccell.2021.02.002
   PubMed Web of Science ®Google Scholar
• van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet. 2011;378(9804):1741–1755. doi:10.1016/S0140-6736(11)60165-7
   PubMed Web of Science ®Google Scholar
• Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2580-patient. Southwest Oncol Group Database. 1990;8:1563–1574.
   Google Scholar
• Hong X, Cui B, Wang M, Yang Z, Wang L, Xu Q. Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer. Tohoku J Exp Med. 2015;236(4):297–304. doi:10.1620/tjem.236.297
   PubMed Web of Science ®Google Scholar
• Wang C, Jin S, Xu S, Cao S. High Systemic Immune-Inflammation Index (SII) represents an unfavorable prognostic factor for small cell lung cancer treated with etoposide and platinum-based chemotherapy. Lung. 2020;198(2):405–414. doi:10.1007/s00408-020-00333-6
   PubMed Web of Science ®Google Scholar
• Jin S, Cao S, Xu S, Wang C, Meng Q, Yu Y. Clinical impact of pretreatment prognostic nutritional index (PNI) in small cell lung cancer patients treated with platinum-based chemotherapy. Clin Respir J. 2018;12(9):2433–2440. doi:10.1111/crj.12925
   PubMed Web of Science ®Google Scholar
• Kinoshita F, Yamashita T, Oku Y, et al. Prognostic impact of Albumin-bilirubin (ALBI) grade on non-small lung cell carcinoma: a propensity-score matched analysis. Anticancer Res. 2021;41(3):1621–1628. doi:10.21873/anticanres.14924
   PubMed Web of Science ®Google Scholar
• Galizia G, Lieto E, Auricchio A, et al. Naples prognostic score, based on nutritional and inflammatory status, is an independent predictor of long-term outcome in patients undergoing surgery for colorectal cancer. Dis Colon Rectum. 2017;60(12):1273–1284. doi:10.1097/DCR.0000000000000961
   PubMed Web of Science ®Google Scholar
• Yang Q, Chen T, Yao Z, Zhang X. Prognostic value of pretreatment Naples prognostic score (NPS) in patients with osteosarcoma. World J Surg Oncol. 2020;18(1):24. doi:10.1186/s12957-020-1789-z
   PubMed Web of Science ®Google Scholar
• Li Q, Cong R, Wang Y, et al. Naples prognostic score is an independent prognostic factor in patients with operable endometrial cancer: results from a retrospective cohort study. Gynecol Oncol. 2021;160(1):91–98. doi:10.1016/j.ygyno.2020.10.013
   PubMed Web of Science ®Google Scholar
• Nakagawa N, Yamada S, Sonohara F, et al. Clinical implications of Naples prognostic score in patients with resected pancreatic cancer. Ann Surg Oncol. 2020;27(3):887–895. doi:10.1245/s10434-019-08047-7
   PubMed Web of Science ®Google Scholar
• Liang W, Ferrara N. The complex role of neutrophils in tumor angiogenesis and metastasis. Cancer Immunol Res. 2016;4(2):83–91. doi:10.1158/2326-6066.CIR-15-0313
   PubMed Web of Science ®Google Scholar
• Grieshober L, Graw S, Barnett MJ, et al. Pre-diagnosis neutrophil-to-lymphocyte ratio and mortality in individuals who develop lung cancer. Cancer Causes Control. 2021;32(11):1227–1236. doi:10.1007/s10552-021-01469-3
   PubMed Web of Science ®Google Scholar
• Hendry S, Salgado R, Gevaert T, et al. Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immuno oncology biomarkers working group: Part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research. Adv Anat Pathol. 2017;24(5):235–251. doi:10.1097/PAP.0000000000000162
   PubMed Web of Science ®Google Scholar
• Mei Z, Liu Y, Liu C, et al. Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis. Br J Cancer. 2014;110(6):1595–1605. doi:10.1038/bjc.2014.46
   PubMed Web of Science ®Google Scholar
• Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–230. doi:10.1016/j.critrevonc.2013.03.010
   PubMed Web of Science ®Google Scholar
• Chan JC, Chan DL, Diakos CI, et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg. 2017;265(3):539–546. doi:10.1097/SLA.0000000000001743
   PubMed Web of Science ®Google Scholar
• Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S. Tumor associated macrophages and neutrophils in cancer. Immunobiology. 2013;218(11):1402–1410. doi:10.1016/j.imbio.2013.06.003
   PubMed Web of Science ®Google Scholar
• Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14(7):399–416. doi:10.1038/nrclinonc.2016.217
   PubMed Web of Science ®Google Scholar
• McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr. 2009;12(3):223–226. doi:10.1097/MCO.0b013e32832a7902
   PubMed Web of Science ®Google Scholar
• Lien YC, Hsieh CC, Wu YC, et al. Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastrointest Surg. 2004;8(8):1041–1048. doi:10.1016/j.gassur.2004.09.033
   PubMed Web of Science ®Google Scholar
• Li SJ, Lv WY, Du H, et al. Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator for patients undergoing minimally invasive lung cancer surgery: propensity score matching analysis using a prospective database. Int J Surg. 2019;69:32–42. doi:10.1016/j.ijsu.2019.07.008
   PubMed Web of Science ®Google Scholar
• Zhang G, Zhang D, Wu J, et al. Low serum levels of pre-surgical total cholesterol are associated with unfavorable overall survival in patients with operable non-small cell lung cancer. Clin Lab. 2018;64(3):321–327. doi:10.7754/Clin.Lab.2017.170823
   PubMed Web of Science ®Google Scholar
• Fearon KC, Voss AC, Hustead DS. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83(6):1345–1350. doi:10.1093/ajcn/83.6.1345
   PubMed Web of Science ®Google Scholar
• Huang Z, Wang X, Zou Q, et al. High platelet-to-lymphocyte ratio predicts improved survival outcome for perioperative NSAID use in patients with rectal cancer. Int J Colorectal Dis. 2020;35(4):695–704. doi:10.1007/s00384-020-03528-8
   PubMed Web of Science ®Google Scholar
• Guo W, Cai S, Zhang F, et al. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer. Thorac Cancer. 2019;10(4):761–768. doi:10.1111/1759-7714.12995
   PubMed Web of Science ®Google Scholar
• Shepshelovich D, Xu W, Lu L, et al. Body Mass Index (BMI), BMI change, and overall survival in patients with SCLC and NSCLC: a pooled analysis of the international lung cancer consortium. J Thorac Oncol. 2019;14(9):1594–1607. doi:10.1016/j.jtho.2019.05.031
   PubMed Web of Science ®Google Scholar